发明名称 ADJUVANTED INFLUENZA VIRUS COMPOSITIONS
摘要 The present invention relates to influenza vaccine formulations and vaccination regimes for immunising against influenza disease, their use in medicine, in particular their use in augmenting immune responses to various antigens, and to methods of preparation. In particular, the invention relates to multivalent influenza immunogenic compositions comprising an influenza antigen or antigenic preparation thereof from at least two influenza virus strains, at least one strain being associated with a pandemic outbreak or having the potential to be associated with a pandemic outbreak, in combination with an oil-in-water emulsion adjuvant.
申请公布号 US2014363474(A1) 申请公布日期 2014.12.11
申请号 US201414465055 申请日期 2014.08.21
申请人 GlaxoSmithKline Biologicals, sa 发明人 HANON Emmanuel Jules;STEPHENNE Jean
分类号 A61K39/145;C12N7/00;A61K39/39 主分类号 A61K39/145
代理机构 代理人
主权项
地址 Rixensart BE